Proanthocyanidins Should Be a Candidate in the Treatment of Cancer, Cardiovascular Diseases and Lipid Metabolic Disorder
The conventional view of using medicines as routine treatment of an intractable disease is being challenged in the face of extensive and growing evidence that flavonoids in foods, especially proanthocyanidins (PAs), can participate in tackling fatal diseases like cancer, cardiovascular and lipid met...
Main Authors: | Tsz Ki Wang, Shaoting Xu, Shuang Li, Yunjian Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-12-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/25/24/5971 |
Similar Items
-
Catechins and Proanthocyanidins Involvement in Metabolic Syndrome
by: Giuseppe Tancredi Patanè, et al.
Published: (2023-05-01) -
Cranberry Proanthocyanidins as a Therapeutic Strategy to Curb Metabolic Syndrome and Fatty Liver-Associated Disorders
by: Francis Feldman, et al.
Published: (2022-12-01) -
Effects of Dietary Supplementation of Peanut Skin Proanthocyanidins on Growth Performance and Lipid Metabolism of the Juvenile American Eel (<i>Anguilla rostrata</i>)
by: Yue Wang, et al.
Published: (2022-09-01) -
Proanthocyanidin-Rich Grape Seed Extract Reduces Inflammation and Oxidative Stress and Restores Tight Junction Barrier Function in Caco-2 Colon Cells
by: Rameshprabu Nallathambi, et al.
Published: (2020-06-01) -
The Synergistic Effect of Proanthocyanidin and HDAC Inhibitor Inhibit Breast Cancer Cell Growth and Promote Apoptosis
by: Tsz Ki Wang, et al.
Published: (2023-06-01)